Kras G12c-mutant Solid Tumor
📧 Sign up to get email alerts when something new happens for Kras G12c-mutant Solid Tumor.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2021-11-15Clinical Trial Update: A Phase 1/2, Study of YL-15293 in Subjects With Advanced Solid Tumors With a KRAS G12C Mutation [Phase 1, Phase 2]
Phase 1/2 study of YL-15293 in advanced solid tumors with KRAS G12C mutation is ongoing with unknown status.